Pregnancy Outcomes in Women Infected with Chlamydia Trachomatis: a Population-based Cohort Study in Washington State

Overview

Journal Sex Transm Infect

Specialty Infectious Diseases

Date 2007 Mar 9

PMID 17344249

Citations 48

Authors

Magaly M Blas

Fredy A Canchihuaman

Isaac E Alva

Stephen E Hawes

Affiliations

Soon will be listed here.

Abstract

Objectives: To measure the risk of preterm delivery, premature rupture of membranes, infant low birth weight and infant mortality, by a population-based retrospective cohort study using Washington State birth certificate data.

Methods: All women diagnosed with Chlamydia trachomatis infection (n = 851), noted with a check box on the birth certificate from 2003, and a randomly selected sample of women not diagnosed with C trachomatis (n = 3404) were identified. To assess the RR between chlamydia infection and pregnancy outcomes, multivariable logistic regression analysis was used.

Results: Women with chlamydia infection were younger, more likely to be non-white and had less years of education compared with women without chlamydia. Additionally, they were more likely to have inadequate prenatal care and coinfections with other sexually transmitted infections. After adjusting for age and education, chlamydia-infected women were at an increased risk of preterm delivery (RR 1.46, 95% CI 1.08 to 1.99) and premature rupture of membranes (RR 1.50, 95% CI 1.03 to 2.17) compared with non-infected women. However, no increased risk of infant death (RR 1.02, 95% CI 0.37 to 2.80) or low birth weight (RR 1.12, 95% CI 0.74 to 1.68) associated with chlamydia infection was observed.

Conclusion: This study suggests that C trachomatis is associated with an increased risk of preterm delivery and premature rupture of membranes, but not with infant death and low birth weight. Routine screening and opportune treatment for C trachomatis should be considered a necessary part of prenatal care to reduce these adverse pregnancy outcomes.

Citing Articles

The prioritisation of curable sexually transmitted infections among pregnant women in Zambia and Papua New Guinea: Qualitative insights.

Vallely L, Kapungu K, Mengi A, Chaponda M, Chico R, Riddell M PLOS Glob Public Health. 2024; 4(7):e0003441.

PMID: 39084601 PMC: 11290942. DOI: 10.1371/journal.pgph.0003441.

Relationship between Vaginal Bacterial Infections and Pregnancy Outcomes: A Systematic Review and Meta-Analysis.

Rokni H, Ahmadi A, Moradi Y, Nouri B, Roshani D Iran J Nurs Midwifery Res. 2024; 29(1):1-15.

PMID: 38333348 PMC: 10849289. DOI: 10.4103/ijnmr.ijnmr_199_22.

Maternal Infection and Preterm Birth: From Molecular Basis to Clinical Implications.

Daskalakis G, Psarris A, Koutras A, Fasoulakis Z, Prokopakis I, Varthaliti A Children (Basel). 2023; 10(5).

PMID: 37238455 PMC: 10217143. DOI: 10.3390/children10050907.

Effectiveness of chlamydia Test and Treat strategy in preventing adverse pregnancy outcomes: protocol for a randomized controlled trial.

Liu L, Li C, Sun X, Yang B, Zheng H, Li M Front Public Health. 2023; 11:1121888.

PMID: 37181719 PMC: 10174107. DOI: 10.3389/fpubh.2023.1121888.

Chlamydia trachomatis plasmid-encoding Pgp3 protein induces secretion of distinct inflammatory signatures from HeLa cervical epithelial cells.

Cheong H, Cheok Y, Chan Y, Tang T, Sulaiman S, Looi C BMC Microbiol. 2023; 23(1):58.

PMID: 36870960 PMC: 9985209. DOI: 10.1186/s12866-023-02802-3.

References

Rastogi S, Salhan S, Mittal A . Detection of Chlamydia trachomatis antigen in spontaneous abortions. Is this organism a primary or secondary indicator of risk?. Br J Biomed Sci. 2000; 57(2):126-9. View

Vogel I, Thorsen P, Hogan V, Schieve L, Jacobsson B, Ferre C . The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes. Acta Obstet Gynecol Scand. 2006; 85(7):778-85. DOI: 10.1080/00016340500442423. View

Gencay M, Koskiniemi M, Ammala P, Fellman V, Narvanen A, Wahlstrom T . Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery. APMIS. 2000; 108(9):584-8. DOI: 10.1034/j.1600-0463.2000.d01-101.x. View

. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002; 51(RR-6):1-78. View

Berg A, Allan J, Frame P, Homer C, Lieu T, Mulrow C . Screening for chlamydia infection: recommendations and rationale. U.S. Preventive Services Task Force. Am J Nurs. 2002; 102(10):87-92; discussion 93. View

Mardh P . Influence of infection with Chlamydia trachomatis on pregnancy outcome, infant health and life-long sequelae in infected offspring. Best Pract Res Clin Obstet Gynaecol. 2002; 16(6):847-64. DOI: 10.1053/beog.2002.0329. View

Martin D, Koutsky L, Eschenbach D, Daling J, ALEXANDER E, Benedetti J . Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA. 1982; 247(11):1585-8. View

Harrison H, ALEXANDER E, WEINSTEIN L, Lewis M, Nash M, Sim D . Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA. 1983; 250(13):1721-7. View

. Chlamydia trachomatis infections. Policy guidelines for prevention and control. MMWR Suppl. 1985; 34(3):53S-74S. View

10.

Gravett M, Nelson H, Derouen T, Critchlow C, Eschenbach D, Holmes K . Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA. 1986; 256(14):1899-903. View

11.

Berman S, Harrison H, Boyce W, Haffner W, Lewis M, Arthur J . Low birth weight, prematurity, and postpartum endometritis. Association with prenatal cervical Mycoplasma hominis and Chlamydia trachomatis infections. JAMA. 1987; 257(9):1189-94. View

12.

Washington A, Johnson R, Sanders Jr L . Chlamydia trachomatis infections in the United States. What are they costing us?. JAMA. 1987; 257(15):2070-2. View

13.

Martius J, Krohn M, Hillier S, Stamm W, Holmes K, Eschenbach D . Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol. 1988; 71(1):89-95. View

14.

Alger L, Lovchik J, Hebel J, Blackmon L, Crenshaw M . The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol. 1988; 159(2):397-404. DOI: 10.1016/s0002-9378(88)80093-0. View

15.

RYAN Jr G, Abdella T, McNeeley S, Baselski V, Drummond D . Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol. 1990; 162(1):34-9. DOI: 10.1016/0002-9378(90)90815-o. View

16.

Cohen I, Veille J, Calkins B . Improved pregnancy outcome following successful treatment of chlamydial infection. JAMA. 1990; 263(23):3160-3. View

17.

Brunham R, Peeling R, Maclean I, Kosseim M, PARASKEVAS M . Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates. J Infect Dis. 1992; 165(6):1076-81. DOI: 10.1093/infdis/165.6.1076. View

18.

Witkin S, Ledger W . Antibodies to Chlamydia trachomatis in sera of women with recurrent spontaneous abortions. Am J Obstet Gynecol. 1992; 167(1):135-9. DOI: 10.1016/s0002-9378(11)91647-0. View

19.

Ekwo E, Gosselink C, Woolson R, Moawad A . Risks for premature rupture of amniotic membranes. Int J Epidemiol. 1993; 22(3):495-503. DOI: 10.1093/ije/22.3.495. View

20.

Kotelchuck M . An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health. 1994; 84(9):1414-20. PMC: 1615177. DOI: 10.2105/ajph.84.9.1414. View